![]() |
|
|
R Rozental, GT Scoble, EX Albuquerque, M Idriss, S Sherby, DB Sattelle, K Nakanishi, K Konno, AT Eldefrawi and ME Eldefrawi
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore.
The effects of pure philanthotoxin (PhTX), a component of the venom of the wasp Philanthus triangulum, were studied on nicotinic acetylcholine receptors (nAChRs) of vertebrates and insects so as to compare their sensitivities and the mechanism of action of PhTX. Electrophysiological techniques were used on frog muscles and cockroach thoracic ganglia and biochemical techniques were applied to membranes from Torpedo electric organ and honeybee brain. PhTX (1-20 microM) inhibited reversibly the indirectly elicited muscle twitch and reduced the endplate current peak amplitude and its decay time constant in a concentration-dependent manner. In patch clamp studies, PhTX (1-5 microM) when combined with acetylcholine, induced a concentration-dependent decrease in frequency of channel openings and in channel open and burst times. The cockroach fast coxal depressor neuron was inhibited by PhTX in a time- and voltage-dependent manner. The initial rate of binding of [3H]perhydrohistrionicotoxin to Torpedo nAChR in the presence of carbamylcholine was inhibited competitively by PhTX. Binding of alpha- [125I] bungarotoxin to electric organ and honeybee brain membranes was inhibited by PhTX. Binding of [3H]acetylcholine to the electric organ receptor was potentiated by low concentrations of PhTX but inhibited by high concentrations. PhTX, therefore, inhibits both vertebrate and insect nAChRs, which may be important molecular targets for its toxicity. It is suggested that PhTX at high concentration may have some competitive action on nAChR, but it acts mainly as a blocker of the ion channel of the nAChR in its open conformation.
This article has been cited by other articles:
![]() |
T. J. Brier, I. R. Mellor, D. B. Tikhonov, I. Neagoe, Z. Shao, M. J. Brierley, K. Stromgaard, J. W. Jaroszewski, P. Krogsgaard-Larsen, and P. N. R. Usherwood Contrasting Actions of Philanthotoxin-343 and Philanthotoxin-(12) on Human Muscle Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2003; 64(4): 954 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Papke Enhanced Inhibition of a Mutant Neuronal Nicotinic Acetylcholine Receptor by Agonists: Protection of Function by (E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403) J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagata, J.-H. Song, T. Shono, and T. Narahashi Modulation of the Neuronal Nicotinic Acetylcholine Receptor-Channel by the Nitromethylene Heterocycle Imidacloprid J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 731 - 738. [Abstract] [Full Text] |
||||